Bitte lesen Sie den vollständigen Hinweis für weitere Informationen, einschließlich dessen, was Kanadier tun sollten, und der Arbeit von Health Canada, um das Problem von Azido-Verunreinigungen in bestimmten Arzneimitteln anzugehen.
| Produkt | Firma | DIN | Los | Ablauf |
| MINZE-LOSARTAN/HCTZ 50/12.5 mg TABLETTEN | Minze Pharmaceuticals Inc. | 02389657 | 2005006959 | April 2023 |
| MINZE-LOSARTAN/HCTZ 50/12.5 mg TABLETTEN | Minze Pharmaceuticals Inc. | 02389657 | 2005006960 | April 2023 |
| MINZE-LOSARTAN/HCTZ 50/12.5 mg TABLETTEN | Minze Pharmaceuticals Inc. | 02389657 | 2005006961 | April 2023 |
| MINZE-LOSARTAN/HCTZ 50/12.5 mg TABLETTEN | Minze Pharmaceuticals Inc. | 02389657 | 2005006962 | April 2023 |
| MINZE-LOSARTAN/HCTZ 50/12.5 mg TABLETTEN | Minze Pharmaceuticals Inc. | 02389657 | 2005006963 | April 2023 |
| MINZE-LOSARTAN/HCTZ 50/12.5 mg TABLETTEN | Minze Pharmaceuticals Inc. | 02389657 | 2005011154 | Juni 2023 |
| MINZE-LOSARTAN/HCTZ 50/12.5 mg TABLETTEN | Minze Pharmaceuticals Inc. | 02389657 | 2005011156 | Juni 2023 |
| MINZE-LOSARTAN/HCTZ 100/12.5 mg TABLETTEN | Minze Pharmaceuticals Inc. | 02389665 | 2005006807 | April 2022 |
| MINZE-LOSARTAN/HCTZ 100/12.5 mg TABLETTEN | Minze Pharmaceuticals Inc. | 02389665 | 2005006808 | April 2022 |
| MINZE-LOSARTAN/HCTZ 100/12.5 mg TABLETTEN | Minze Pharmaceuticals Inc. | 02389665 | 2005006809 | April 2022 |
| MINZE-LOSARTAN/HCTZ 100/12.5 mg TABLETTEN | Minze Pharmaceuticals Inc. | 02389665 | 2005006810 | April 2022 |
| MINZE-LOSARTAN/HCTZ 100/12.5 mg TABLETTEN | Minze Pharmaceuticals Inc. | 02389665 | 2105002149 | Dezember 2022 |
| MINZE-LOSARTAN/HCTZ DS 100/25 mg TABLETTEN | Minze Pharmaceuticals Inc. | 02389673 | 1805012687 | Oktober 2021 |
| MINZE-LOSARTAN/HCTZ DS 100/25 mg TABLETTEN | Minze Pharmaceuticals Inc. | 02389673 | 1805012688 | Oktober 2021 |
| MINZE-LOSARTAN/HCTZ DS 100/25 mg TABLETTEN | Minze Pharmaceuticals Inc. | 02389673 | 1805012689 | Oktober 2021 |
| MINZE-LOSARTAN/HCTZ DS 100/25 mg TABLETTEN | Minze Pharmaceuticals Inc. | 02389673 | 1805012792 | Oktober 2021 |
| MINZE-LOSARTAN/HCTZ DS 100/25 mg TABLETTEN | Minze Pharmaceuticals Inc. | 02389673 | 1905001010 | Dezember 2021 |
| MINZE-LOSARTAN/HCTZ DS 100/25 mg TABLETTEN | Minze Pharmaceuticals Inc. | 02389673 | 1905001011 | Dezember 2021 |
| MINZE-LOSARTAN/HCTZ DS 100/25 mg TABLETTEN | Minze Pharmaceuticals Inc. | 02389673 | 2005006947 | April 2023 |
| MINZE-LOSARTAN/HCTZ DS 100/25 mg TABLETTEN | Minze Pharmaceuticals Inc. | 02389673 | 2005006949 | April 2023 |
| MINZE-LOSARTAN/HCTZ DS 100/25 mg TABLETTEN | Minze Pharmaceuticals Inc. | 02389673 | 2005006950 | April 2023 |
| MINZE-LOSARTAN/HCTZ DS 100/25 mg TABLETTEN | Minze Pharmaceuticals Inc. | 02389673 | 2005006951 | April 2023 |
| MINZE-LOSARTAN/HCTZ DS 100/25 mg TABLETTEN | Minze Pharmaceuticals Inc. | 02389673 | 2005007297 | April 2023 |
| MINZE-LOSARTAN/HCTZ DS 100/25 mg TABLETTEN | Minze Pharmaceuticals Inc. | 02389673 | 2005007298 | April 2023 |
| MINZE-LOSARTAN/HCTZ DS 100/25 mg TABLETTEN | Minze Pharmaceuticals Inc. | 02389673 | 2005013776 | August 2023 |
| MINZE-LOSARTAN/HCTZ DS 100/25 mg TABLETTEN | Minze Pharmaceuticals Inc. | 02389673 | 2105002150 | Dezember 2023 |
WAS SIE AUS DIESEM ARTIKEL MITNEHMEN KÖNNEN:
- 023896732005006947April 2023MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSMint Pharmaceuticals Inc.
- 023896732005006949April 2023MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSMint Pharmaceuticals Inc.
- 023896732005006950April 2023MINT-LOSARTAN/HCTZ DS 100/25 mg TABLETSMint Pharmaceuticals Inc.
